Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
This kit is for the detection of Mouse FLT3LG / Flt3 Ligand. No significant cross-reactivity or interference between FLT3LG / Flt3 Ligand and analogs was observed. This claim is limited by existing techniques therefore cross-reactivity may exist with untested analogs.
LS-F28695 is a 96-well enzyme-linked immunosorbent assay (ELISA) for the Quantitative detection of Mouse FLT3LG / Flt3 Ligand in samples of Plasma and Serum. It is based upon a Sandwich assay principle and can be used to detect levels of FLT3LG / Flt3 Ligand as low as 1 picograms per milliliter.
96-Well Strip Plate
Colorimetric - 450nm (TMB)
250 - 5000 pg/ml
Intra-Assay: CV%<9% Inter-Assay: CV%<10%
Due to their limited shelf life, LSBio ELISA kits are not typically stocked as finished goods. Upon receipt of an order each kit is assembled and tested to ensure that it meets specifications before shipping. Minor changes may occur to the Range, Sensitivity, and Precision. In the event of a significant change the order would be confirmed with the customer before shipping ELISA kit lot numbers reflect the date of final assembly and testing for each specific kit rather than a bulk manufactured lot. All kits are tested to confirm that they fall within their defined Inter- and Intra- assay coefficient of variation.
Dendritic cells (DCs) provide the key link between innate and adaptive immunity by recognizing pathogens and priming pathogen-specific immune responses. FLT3LG controls the development of DCs and is particularly important for plasmacytoid DCs and CD8 (see MIM 186910)-positive classical DCs and their CD103 (ITGAE; MIM 604682)-positive tissue counterparts (summary by Sathaliyawala et al., 2010 [PubMed 20933441]).